Refine by
Diagnostic Kit Articles & Analysis
18 news found
Creative Diagnostics, a global leader in providing raw materials, antibodies, and reagents for the biotechnology industry, recently introduced comprehensive contract ELISA kit development services to the R&D and IVD communities, facilitating regulatory approval submissions. With expertise in antibody generation and immunoassay development, Creative Diagnostics can generate various diagnostic ...
Creative Enzymes, a worldwide leading company in diagnostic enzymes manufacturing and supply, is committed to providing customers with diverse enzyme products and custom enzyme-related services for medical and research diagnosis. Recently, Creative Enzymes launched the raw materials for manufacturing Diagnostic Kits. The raw materials provided by Creative Enzymes include enzymes for cholesterol ...
Amerigo Scientific, a distribution company focused on providing critical products and services to the biomedical and life science research communities, now introduces Polystreptavidin 350 for applications in lateral flow, ELISA or CLIA. Diagnosis is a key enabler of universal health coverage and the first line of defense against the spread of many diseases. From rapid treatment and combating ...
Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today issued a corporate update in a Letter to Shareholders filed in its certified shareholder report on Form N-CSR on February 28, 2022 from CEO & President, Michael Feldschuh. Dear Fellow Shareholder: It is not every day you get to walk into Times Square in New York City and see your face and ...
ImCare Biotech has been awarded a Phase IIB Bridge Award by the National Cancer Institute (NCI/NIH). This up to $4M over three-year award will be used to help ImCare Biotech pursue commercialization activities and support a pivotal clinical study for FDA clearance of Seravue®, a diagnostic testing product for Hepatocellular Carcinoma (HCC). This follows the promising results of a phase II ...
Thermo Fisher Scientific Inc., (NYSE:TMO) the world leader in serving science, today announced continuing support for The Just Project, a national initiative to provide COVID-19 testing to students, faculty and staff across more than 60 historically black colleges and universities (HBCUs) at no cost. A $7.5 million commitment for the 2021-2022 school year will once again provide diagnostic ...
The 221b Foundation, a nonprofit organization established by Sherlock Biosciences to address the global COVID-19 pandemic while promoting diverse representation in STEM, today announced that it has granted a license to ALBOT USA and ALBOT Technologies Private Limited India to develop, manufacture and distribute COVID-19 diagnostic tests using Sherlock’s CRISPR technology. ALBOT has current ...
The 221b Foundation, a nonprofit organization established by Sherlock Biosciences to address the global COVID-19 pandemic while promoting diverse representation in STEM, today announced that it has granted Cooper International and United PPE licenses to develop and manufacture COVID-19 diagnostic tests using Sherlock’s CRISPR technology. The agreements will increase access in Asia and the ...
Newsight Imaging, an Israeli startup developing imaging solutions and chips for spectral and machine vision applications, announced today that the company’s SpectraLIT device, powered by Virusight Diagnostic’s AI software, which enables a ground-breaking 20-second COVID-19 diagnosis, has received the Conformité Européene (CE-European Conformity) Mark approval. ...
The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for the Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit from Thermo Fisher Scientific, the company announced today. The TaqPath COVID-19, Flu A, Flu B Combo Kit is a real-time PCR test for the detection and differentiation of RNA from the SARS-CoV2, influenza A and influenza B viruses in ...
Thermo Fisher Scientific announces CE-marking of its TaqPath COVID-19, Flu A/B, RSV Combo Kit for the in vitro diagnosis of SARS-CoV-2, influenza A/B and respiratory syncytial virus (RSV) A/B infections. Using the new kit, laboratories can now can run a single test for SARS-CoV-2, influenza (flu) A/B, and RSV to detect and differentiate between diseases that share similar clinical symptoms, and ...
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, has committed to supporting the efforts of historically black colleges and universities (HBCUs) in the U.S. to make COVID-19 testing available to all returning students, faculty and staff at the beginning of the fall semester. Through an initiative called "The Just Project," named after pioneering biologist Ernest ...
Thermo Fisher Scientific and First Genetics JCS, a manufacturer of diagnostic equipment and IVD kits intended to advance molecular genetic technologies into clinical practice, today announced a strategic partnership focused on commercializing next-generation sequencing (NGS)–based diagnostics in Russia. The agreement enables First Genetics to market its F-Genetics NGS System and IVD assays ...
Neogen announced today the launch of K-Gold® Plus, a new PNPP (p-nitrophenyl phosphate) substrate that combines the ease of use of its previous PNPP substrate with an improved signal-to-background performance. Similar to the original formulation, Neogen’s new K-Gold Plus is a one-bottle, ready-to-use solution that offers long-term stability and non-hazardous labeling. K-Gold Plus also ...
ImCare Biotech has been awarded Phase II grant by NCI (NIH) for its project on development of a diagnostic kit for early detection of liver cancer. ...
There is a huge gap between the state of the art of health care, which is available in urban areas and developed countries, and the kind of healthcare services available to the rural population in developing countries. Many people in poorer societies suffer because of unavailability of simple and standard medical facilities and diagnostics. Neurosynaptic Communications plans to bridge this gap ...
Vybion has received a $1.3M subcontract on at $7.1M NIH Cooperative Agreement to develop diagnostics for Lassa Virus, a deadly hemorrhagic virus endemic in West Africa. Researchers at Tulane University, in collaboration with Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, have received a five-year $7.07 million grant from the National Institutes of Health ...
ByVybion
Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, has announced an expansion of the collaborative effort for developing test kits for viral hemorrhagic fever (VHF) detection... Joining the collaboration is Vybion, Inc., an Ithaca, N.Y., based biotechnology company. Vybion CEO Lee Henderson, Ph.D., stated, "We are pleased to be ...
ByVybion